Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Buprenorphine”

594 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 594 results

Post-approval studies (Phase 4)WithdrawnNCT03335436
What this trial is testing

Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient

Who this might be right for
Cesarean DeliveryPain Management
Vanderbilt University Medical Center
Testing effectiveness (Phase 2)Study completedNCT00000233
What this trial is testing

Alternate Day Buprenorphine Administration, Phase X - 15

Who this might be right for
Opioid-Related Disorders
National Institute on Drug Abuse (NIDA)
Large-scale testing (Phase 3)Study completedNCT02896296
What this trial is testing

Open-Label Treatment Extension Study

Who this might be right for
Opioid Use DisorderOpioid-related Disorders
Indivior Inc. 208
Early research (Phase 1)Not Yet RecruitingNCT07314346
What this trial is testing

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Who this might be right for
Healthy Volunteer Study
Atea Pharmaceuticals, Inc. 32
Not applicableStudy completedNCT00134888
What this trial is testing

Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence

Who this might be right for
Opioid-Related Disorders
National Institute on Drug Abuse (NIDA) 8
Large-scale testing (Phase 3)Study completedNCT02363998
What this trial is testing

Open-Label, Safety Study of Lofexidine

Who this might be right for
Opioid Withdrawal
USWM, LLC (dba US WorldMeds) 286
Early research (Phase 1)Study completedNCT02508506
What this trial is testing

Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Alkermes, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT02263248
What this trial is testing

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine

Who this might be right for
Major Depressive DisorderDepression
Centre for Addiction and Mental Health 56
Not applicableStudy completedNCT02942199
What this trial is testing

MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)

Who this might be right for
Opioid Use Disorder
Cambridge Health Alliance 12
Testing effectiveness (Phase 2)Study completedNCT00315835
What this trial is testing

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

Who this might be right for
Postoperative Pain
Purdue Pharma LP 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT06880718
What this trial is testing

Injectable Buprenorphine in Prison: a Preference Trial

Who this might be right for
Opioid Use DisorderIncarcerationMedications for Opioid Use Disorder+1 more
Lifespan 60
Testing effectiveness (Phase 2)Ended earlyNCT00403234
What this trial is testing

Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

Who this might be right for
Postoperative Pain
Purdue Pharma LP 10
Early research (Phase 1)Study completedNCT01999114
What this trial is testing

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

Who this might be right for
ECG Effects
Purdue Pharma LP 328
Post-approval studies (Phase 4)Study completedNCT01818700
What this trial is testing

An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders

Who this might be right for
Spinal Disorder
Mundipharma Korea Ltd 245
Not applicableStudy completedNCT05184907
What this trial is testing

Effects of RME on Engagement in Buprenorphine Treatment

Who this might be right for
Opioid Use DisorderBehavioral SymptomsPsychiatric or Mood Diseases or Conditions
Cambridge Health Alliance 25
Not applicableNot Yet RecruitingNCT07202039
What this trial is testing

Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine

Who this might be right for
Tobacco-flavored ECSweet-Cooling ECSweet Non-cooling EC
Prisma Health-Upstate 90
Post-approval studies (Phase 4)Study completedNCT00844272
What this trial is testing

Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment

Who this might be right for
Intravenous Drug AbuseChronic Hepatitis C
Universitätsklinikum Hamburg-Eppendorf 189
Large-scale testing (Phase 3)Ended earlyNCT00320801
What this trial is testing

Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.

Who this might be right for
Osteoarthritis
Purdue Pharma LP 188
Testing effectiveness (Phase 2)Study completedNCT05063201
What this trial is testing

Cariprazine for Comorbid Cocaine and Opioid Use Disorder

Who this might be right for
Opioid-use DisorderCocaine Use Disorder
Kyle Kampman 26
Large-scale testing (Phase 3)Study completedNCT01131273
What this trial is testing

HIV Risk Reduction in Subutex Injectors in Tbilisi

Who this might be right for
HIV
University of Pennsylvania 68
Load More Results